Vet Medicine: Longevity Pills, Vet Shortages and Bills — 2026-10-26
The FDA has approved a new antibiotic formulation for dogs and recalled thousands of compounded veterinary medications this week amid a nationwide drug shortage. Meanwhile, Loyal’s dog longevity drug LOY-002.3 is nearing conditional approval, potentially available by late 2026, as rising pet care costs and staffing gaps continue to squeeze veterinary practices and owners alike.
Vet Medicine: Longevity Pills, Vet Shortages and Bills — 2026-10-26
Top developments
FDA Approves New Antibiotic, Recalls Thousands of Compounded Drugs
This week, the FDA’s Center for Veterinary Medicine (CVM) approved a new antibiotic formulation specifically for treating certain skin infections in dogs. Concurrently, a nationwide recall of thousands of compounded veterinary medication listings was announced, addressing safety concerns in the compounded drug supply chain.
Dog Longevity Drug Nears Conditional Approval
Loyal’s drug LOY-002.3, designed to extend the healthy lifespan of senior dogs, has cleared two of the three major technical sections required by the FDA for conditional approval. A veterinarian explained that the pill could be available as early as late 2026 or 2027. The drug targets metabolic pathways similar to caloric restriction, aiming to delay age-related decline in dogs aged 10 and older.
Rising Costs and Staffing Squeeze Veterinary Care
Veterinary practices are facing a dual challenge: rising operational costs and a persistent shortage of veterinarians and nurses. This pressure is driving up prices for pet owners and contributing to pet overpopulation due to limited access to care. Recent reports indicate that pet care costs are rising by as much as 15% in 2026, with vet bills being a primary driver.
Pet Insurance Value Debate Intensifies
As costs rise, the value of pet insurance is under scrutiny. While premiums have fallen in some markets, out-of-pocket claim costs have increased by 20% due to higher excesses and co-payments. Consumers are increasingly wary of coverage gaps, with surveys showing that veterinary care is among the last expenses owners are willing to cut, despite the financial strain.
Local view
In Germany, the debate over the Gebührenordnung für Tierärzte (GOT) continues to impact practice economics. Recent articles from honestdog.de and die-tierversicherer.de highlight how disputes over GOT rates are exacerbating the shortage in veterinary practices, particularly affecting emergency service fees and weekend rates. Local pet owners are advised to understand the specific calculation of emergency fees (Notdienstgebühr) and value-added tax implications to avoid unexpected bills.
Context & numbers
- Drug Status: LOY-002.3 has cleared 2 of 3 FDA technical sections for conditional approval.
- Cost Inflation: Pet care costs are rising up to 15% in 2026.
- Insurance Claims: Despite falling premiums, out-of-pocket costs for claims have risen by 20%.
- Workforce: The SPVS 2026 salary survey is currently open, capturing data on salaries and benefits to benchmark the profession.
On the radar
- Loyal STAY Study: The largest clinical trial in veterinary medicine, involving 1,300 dogs, continues to gather long-term data on the efficacy and safety of LOY-002.3.
- SPVS Salary Survey: Veterinary professionals are encouraged to participate in the 2026 survey to help establish accurate pay benchmarks.
- New Screwworm Detection: The first detection of New World screwworm in US wildlife since the parasite's return was reported this week, raising concerns for livestock and pet health.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
